Overview
Sakiko Otani practices in Tama, Japan. Ms. Otani is rated as an Experienced expert by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Her clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Neurotoxicity Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMs. Otani isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerMs. Otani isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaMs. Otani isExperienced. Learn about Acute Interstitial Pneumonia.
- AgranulocytosisMs. Otani isExperienced. Learn about Agranulocytosis.
- Anal CancerMs. Otani isExperienced. Learn about Anal Cancer.
- Interstitial Lung DiseaseMs. Otani isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaMs. Otani isExperienced. Learn about Lung Adenocarcinoma.
- Neurotoxicity SyndromesMs. Otani isExperienced. Learn about Neurotoxicity Syndromes.